Cost-effectiveness and medical cost-offset considerations in psychological service provision

Canadian Psychology

Volumn 44, Issue 1, 2003, Pages 61-73

  Hunsley, John ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037324658     PISSN: 07085591     EISSN: None     Source Type: Journal    
DOI: 10.1037/h0085818     Document Type: Article

References (74)

1. Antonuccio, D. O., Thomas, M., & Danton, W. G. (1997). A cost-effectiveness analysis of cognitive behavior therapy and Fluoxetine (Prozac). Behavior Therapy, 28, 187-210.
2. Bower, P., Byford, S., Sibbald, B., Ward, E., King, M., Lloyd, M., & Grassay, M. (2000). Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: Cost effectiveness. British Medical Journal, 321, 1389-1392.
3. Briggs, A. H., & Gray, A. M. (1998). Sample size and power caluclations for stochastic cost-effectiveness analysis. Medical Decision Making, 18 (suppl.), 81-92.
4. Budman, S. H. (1999). Whither medical cost offset? Comments on Chiles et al. Clinical Psychology: Science and Practice, 6, 228-231.
5. Canadian Institute for Health Information. (2001a). Health care in Canada 2001. Ottawa, ON: Author.
6. Canadian Institute for Health Information. (2001b). Total health expenditure, by province/territory and Canada 1975 to 2001 - Current dollars. Retrieved January 10, 2002, from http://www.cihi.ca/facts/nhex/nhex2001/b.1.1.shtml.
7. Canadian Institute for Health Information. (2001c). Public sector health expenditure, by province/territory and Canada 1975 to 2001 - Current dollars. Retrieved January 10, 2002, from http://www.cihi.ca/facts/nhex/nhex2001/b.3.1.shtml.
8. Canadian Psychological Association. (1999). Geographic locations survey of clinical psychologists in Canada. Ottawa, ON: Author.
9. Canadian Psychological Association. (2001). Putting human behaviour at the heart of health care in Canada. Ottawa, ON: Author.
10. Candilis, P.J., & Pollack, M. H. (1997). The hidden costs of untreated anxiety disorders. Harvard Review of Psychiatry, 5, 40-42.
11. Chambless, D. L., & Ollendick, T. H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685-716.
12. Chiles, J. A., Lambert, M.J., & Hatch, A. L. (1999). The impact of psychological interventions on medical cost offset: A meta-analytic review. Clinical Psychology: Science and Practice, 6, 204-220.
13. DeRubeis, R. J., Gelfand, L. A., Tang, T. Z., & Simons, A. D. (1999). Medications versus cognitive behavior therapy for severely depressed outpatients: Mega-analysis of four randomized comparisons. American Journal of Psychiatry, 156, 1007-1013.
14. Dobson, K. S. (2002). A national imperative: Public funding of psychological services. Canadian Psychology, 43, 65-75.
15. Druss, B. G., Rosenheck, M. D., & Sledge, W. H. (2000). Health and disability costs of depressive illness in a major U. S. corporation. American Journal of Psychiatry, 157, 1274-1278.
16. Fahrion, S., Norris, P., Green, E., & Schnar, R. (1987). Behavioral treatment of hypertension: A group outcome study. Biofeedback and Self-Regulation, 11, 257-278.
17. Follette, W. T., & Cummings, N. A. (1967). Psychiatric services and medical utilization in a prepaid health plan setting. Medical Care, 5, 25-35.
18. Gabbard, G. O., Lazar, S. G., Hornberger, J., & Spiegel, D. (1997). The economic impact of psychotherapy: A review. American Journal of Psychiatry, 154, 147-155.
19. Golden, G. A. (1997). Impact of psychotherapy: Does it affect frequency of visits to family physicians? Canadian Family Physician, 43, 1098-1102.
20. Gonick, U., Farrow, I., Meier, M., Ostmand, G., Frolick, L. (1981). Cost effectiveness of behavioral medicine procedures in the treatment of stress-related disorders. American Journal of Clinical Biofeedback, 4, 16-24.
21. Gould, R. A., Otto, M. W., & Pollack, M. H. (1995). A meta-analysis of treatment outcome for panic disorder. Clinical Psychology Review, 15, 819-844.
22. Graham, J. D., Thompson, K. M., Goldie, S. J., Segui-Gomez, M., & Weinstein, M. C. (1997). The cost-effectiveness of air bags by seating position. Journal of the American Medical Association, 278, 1418-1425.
23. Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J. (1999). The economic burden of anxiety disorders in the 1990s. Journal of Clinical Psychiatry, 60, 427-435.
24. Groeneveld, P. W., Kwong, J. L., Liu, Y., Rodriguez, A.J., Jones, M. P., Sanders, G. D., & Garber, A. M. (2001). Cost-effectiveness of automated external defibrillators on airlines. Journal of the American Medical Association, 286, 1482-1489.
25. Groth-Marnat, G., & Edkins, G. (1996). Professional psychologists in general health care settings: A review of financial efficacy of direct treatment interventions. Professional Psychology: Research and Practice, 27, 161-174.
26. Hampson, S. E., Skinner, T. C., Hart, J., Storey, L., Gage, H., Foxcroft, D., Kimber, A., Craddock, S., & McEvilly, E. A. (2000). Behavioral interventions for adolescents with type 1 diabetes: How effective are they? Diabetes Care, 23, 416-422.
27. Hargreaves, W. A., Shumway, M., & Hu, T.-W. (1999). Measuring psychotherapy costs and effectiveness. In N. E. Miller & K. M. Magruder (Eds.), Cost-effectiveness of psychotherapy (pp. 85-98). New York: Oxford University Press.
28. Hargreaves, W. A., Shumway, M., Hu, T.-W., & Cuffel, B. (1998). Cost-outcome methods for mental health. San Diego, CA: Academic Press.
29. Hofmann, S. G., & Barlow, D. H. (1999). The costs of anxiety disorders: Implications for psychosocial interventions. In N. E. Miller & K. M. Magruder (Eds.), Cost-effectiveness of psychotherapy (pp. 224-234). New York: Oxford University Press.
30. Holroyd, K. A., O'Donnell, F.J., Stensland, M., Lipchik, G. L., Cordingley, G. E., & Carlson, B. W. (2001). Management of chronic tension-type headache with tri-cyclic antidepressant medication, stress management therapy, and their combination: A randomized controlled trial. Journal of the American Medical Association, 285, 2208-2215.
31. Iglehart, J. K. (2000). Revisiting the Canadian health care system. New England Journal of Medicine, 342, 2007-2012.
32. Jacobs, D. F. (1987). Cost-effectiveness of specialized psychological programs for reducing hospital stays and outpatient visits. Journal of Clinical Psychology, 43, 729-735.
33. Jacobs, D. F. (1988). Marketing psychological services in the public sector. Psychotherapy, 25, 377-386.
34. Jacobson, N. (1995, March/April). The overselling of therapy. Family Therapy Networker, 40-47.
35. Jones, K., & Vischi, T. (1979). The impact of alcohol, drug abuse, and mental health treatment on medical care utilization: A review of the research literature. Medical Care, 17, (Suppl. 12), 43-131.
36. Kashner, T. M., & Rush, A. J. (1999). Measuring medical offsets of psychotherapy. In N. E. Miller & K. M. Magruder (Eds.), Cost-effectiveness of psychotherapy (pp. 109-121). New York: Oxford University Press.
37. Knapp, M., & Healey, A. (1999). Psychotherapy: Individual differences in costs and outcomes. In N. E. Miller & K. M. Magruder (Eds.), Cost-effectiveness of psychotherapy (pp. 122-133). New York: Oxford University Press.
38. Krupnick, J. L., & Pincns, H. A. (1992). The cost-effectiveness of psychotherapy: A plan for research. American Journal of Psychiatry, 149, 1295-1305.
39. Linden, W., & Chambers, L. (1994). Clinical effectiveness of non-drug treatment for hypertension: A meta-analysis. Annals of Behavioral Medicine, 16, 35-45.
40. Linden, W., Stossel, C., & Maurice, J. (1996). Psychosocial interventions for patients with coronary artery disease: A recta-analysis. Archives of Internal Medicine, 156, 745-752.
41. Linehan, M. M., & Heard, H. L. (1999). Borderline personality disorder: Costs, course, and treatment outcomes. In N. E. Miller & K. M. Magruder (Eds.), Cost-effectiveness of psychotherapy (pp. 291-305). New York: Oxford University Press.
42. L'Ordre des psychologues du Québec. (2000). Pour une transformation optimale: des pratiques en santé: la contribution des psychologues. Montréal, QC: Author.
43. Manitoba Psychological Society. (2001). Position on access to psychological services in Manitoba. Winnipeg, MN: Author.
44. Mash, E.J., & Hunsley, J. (1993). Behavior therapy and managed mental health care: Integrating effectiveness and economics in mental health practice. Behavior Therapy, 24, 67-90.
45. Miller, I. J. (1998). Response to "All that glitters is not always gold: Medical offset effects and managed behavioral health care." Professional Psychology: Research and Practice, 29, 622-624.
46. Miller, N. E., & Magruder, K. M. (Eds.). (1999). Cost-effectiveness of psychotherapy. New York: Oxford University Press.
47. Moore, R., Mao, Y., Zhang, J., & Clarke, K. (1997). Economic burden of illness in Canada. Ottawa, ON: Health Canada.
48. Moran, P. W. (1999). Psychological interventions and medical cost offset: Implications for integrative health care. Clinical Psychology: Science and Practice, 6, 242-244.
49. Mumford, E., Schlesinger, H. J., Glass, G. V., Patrick, G., & Cuerdon, T. (1984). A new look at evidence about reduced cost of medical utilization following mental health treatment. American Journal of Psychiatry, 141, 1145-1158.
50. Nathan, P. E., & Gorman, J. M. (Eds.). (1998). A guide to treatments that work. New York: Oxford University Press.
51. New Brunswick Health Services Review Committee (2002). Health services review: Report of the committee. [On-line]. Available http://www.gov.nb.ca/hw-sm/hw/pub/hsrc/summreco.htm.
52. Nezu, A. M., Nezu, C. M., & Lombardo, E. R. (2001). Cognitive-behavior therapy for medically unexplained symptoms: A critical review of the treatment literature. Behavior Therapy, 32, 537-583.
53. O'Farrell, T. J., Choquette, K. A., Cutter, H. S., Floyd, F. J., Bayog, R., Brown, E. D., Lowe, J., Chan, A., & Deneault, P. (1996). Cost-benefit and cost-effectiveness analyses of behavioral marital therapy as an addition to outpatient alcoholism treatment. Journal of Substance Abuse, 8, 145-166.
54. Rosenthal, R. (1984). Meta-analytic procedures for social research. Beverly Hills, CA: Sage.
55. Roth, A. D., & Fonagy, P. (1996). What works for whom? A critical review of psychotherapy research. New York: Guilford.
56. Sadavoy, J., & Perry, J. C. (1999). Psychotherapy services and cost-effectiveness: A Canadian perspective. In N. E. Miller & K. M. Magruder (Eds.), Cost-effectiveness of psychotherapy (pp. 327-333). New York: Oxford University Press.
57. Saskatchewan Psychological Association. (2001). Submission to the Standing Committee on Health Care: Respecting the final report of the Saskatchewan Commission on Medicare (Fyke Report). Regina, SK: Author.
58. Schlesinger, H. J., Mumford, E., Glass, G. V., Patrick, C., & Sharfstein, S. (1983). Mental health treatment and medical care utilization in a fee-for-service system: Outpatient mental health treatment following the onset of a chronic disease. American Journal of Public Health, 73, 422-429
59. Schoenwald, S. K., Ward, D. M., Henggeler, S. W., & Rowland, M. D. (2000). Multisystemic therapy versus hospitalization for crisis stabilization of youth: Placement outcomes four months postreferral. Mental Health Services Research, 2, 3-12.
60. Sharpe, L, Sensky, T., Timberlake, N., Ryan, B., Brewin, C. R., & Allard, S. (2001). A blind, randomized, controlled trial of cognitive-beahviural intervention for patients with recent onset rheumatoid arthritis: Preventing psychological and physical morbidity. Pain, 89, 275-283.
61. Simon, G., Ormel, J., Von Korff, M., & Barlow, W. (1995). Health care costs associated with depressive and anxiety disorders in primary care. American Journal of Psychiatry, 152, 352-357.
62. Simpson, J. S. A., Carlson, L. E., & Trew, M. E. (2001). Effect of group therapy for breast cancer on healthcare utilization. Cancer Practice, 9, 19-26.
63. Spiegel, D. (Ed.). (1999). Efficacy and cost-effectiveness of psychotherapy. Washington, DC: American Psychiatric Press.
64. Stephens, T., & Joubert, N. (2001). The economic burden of mental health problems in Canada. Chronic Diseases in Canada, 22, 18-23.
65. Toeus, C., Kaplan, R., & Atkins, C. (1984). The costs and effects of behavioral programs in chronic obstructive pulmonary disease. Medical Care, 22, 1088-1099.
66. U. K. Department of Health. (2001). Treatment choice in psychological therapies and counselling: Evidence based clinical practice guidelines. London: Author.
67. van Tulder, M. W., Ostelo, R., Vlaeyen, J. W., Linton, S. J., Morley, S. J., & Assendelft, W. J. (2000). Behavioural treatment for chronic low back pain. Cochrane Database Systemic Reviews, CD002014 (latest version February 15, 2000).
68. Von Korff, M., Katon, W., Bush, T., Lin, E. H., Simon, G. E., Saunders, K., Ludman, E., Walker, E., & Unutzer, J. (1998). Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosomatic Medicine, 60, 143-149.
69. Wells, K. B., Sturm, R., Sherbourne, C. D., & Meredith, L. S. (1996). Caring for depression. Cambridge, MA: Harvard University Press.
70. Whiting, P., Bagnall, A.-M., Sowden, A. J., Cornell, J. E., Mulrow, C. D., & Ramirez, G. (2001). Intervention for the treatment and management of chronic fatigue syndrome: A systematic review. Journal of the American Medical Association, 286, 1360-1368.
71. Yates, B. T. (1996). Analyzing costs, procedures, processes, and outcomes in human services. Thousand Oaks, CA: Sage.
72. Yates, B. T. (1997). From psychotherapy research to cost-outcome research: What resources are necessary to implement which therapy procedures that change what processes to yield which outcomes? Psychotherapy Research, 7, 345-364.
73. Young, A. S., Klap, R., Sherbourne, C. D., & Wells, K. B. (2001). The quality of care for depressive and anxiety disorders in the United States. Archives of General Psychiatry, 58, 55-61.
74. Zhang, M., Rost, K. M., & Fortney, J. C. (1999). Earnings changes for depressed individuals treated by mental health specialists. American Journal of Psychiatry, 156, 108-114.